About this book series
Cancer Drug Discovery and Development is the definitive book series in cancer research and oncology, providing comprehensive coverage of specific topics in the field. The aim of the series is to cover the process of drug discovery, preclinical models in cancer research, specific drug target groups and experimental and approved therapeutic agents across volumes.
Volumes are current and timely, anticipating areas where experimental agents are reaching FDA approval. Each volume is edited by an expert in the related field and chapters are authored by renowned scientists and physicians in their fields of interest. All volumes undergo single blind peer review and review by the series editor prior to acceptance and publication in the series. Cancer Drug Discovery & Development is indexed in SCOPUS.
- Electronic ISSN
- 2196-9914
- Print ISSN
- 2196-9906
- Series Editor
-
- Beverly A. Teicher
Book titles in this series
-
-
Molecular Targeted Radiosensitizers
Opportunities and Challenges
- Editors:
-
- Henning Willers
- Iris Eke
- Copyright: 2020
Available Renditions
- Hard cover
- Soft cover
- eBook
-
The Unfolded Protein Response in Cancer
- Editors:
-
- Robert Clarke
- Copyright: 2019
Available Renditions
- Hard cover
- eBook
-
Developments in T Cell Based Cancer Immunotherapies
- Editors:
-
- Paolo A. Ascierto
- David F. Stroncek
- Ena Wang
- Copyright: 2015
Available Renditions
- Hard cover
- Soft cover
- eBook
-
Innovations for Next-Generation Antibody-Drug Conjugates
- Editors:
-
- Marc Damelin
- Copyright: 2018
Available Renditions
- Hard cover
- Soft cover
- eBook
Abstracted and indexed in
-
- EMBASE
- Reaxys
- SCImago
- SCOPUS